Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Zileuton vs Azathioprine/Prednisone in Idiopathic Pulmonary Fibrosis
NCT00262405Phase 2Completed
- Sponsor
- University of Michigan
- Start
- Jan 2001
- Primary completion
- May 2007
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial of zileuton extended release in idiopathic pulmonary fibrosis (IPF) (2 arms), sponsored by University of Michigan. Primary endpoint: Leukotriene B4 level in bronchoalveolar lavage fluid at 6 months. Started Jan 2001; status: completed.
02
Drugs
zileuton extended release
03
Conditions
idiopathic pulmonary fibrosis (IPF)
Beyond the preview
Go deeper on NCT00262405.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00262405.